CARLOS
MACAYA MIGUEL
Profesor emérito
Hospital Universitario Puerta de Hierro
Madrid, EspañaHospital Universitario Puerta de Hierro -ko ikertzaileekin lankidetzan egindako argitalpenak (29)
2024
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study
Cardiovascular Revascularization Medicine, Vol. 40, pp. 50-56
2021
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19
Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
Archivos de Bronconeumologia, Vol. 57, pp. 13-20
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
American Heart Journal, Vol. 237, pp. 104-115
-
Stent strut thickness and acute vessel injury during percutaneous coronary interventions: An optical coherence tomography randomized clinical trial
Coronary Artery Disease, Vol. 32, Núm. 5, pp. 382-390
2020
-
Coronary artery bypass grafting in Spain. Influence of procedural volume on outcomes
Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 488-494
-
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Frontiers in Endocrinology, Vol. 11
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2017
-
Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis
JACC: Cardiovascular Interventions, Vol. 10, Núm. 9, pp. 879-888
2016
-
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes
EuroIntervention, Vol. 12, Núm. 1, pp. 79-87
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
-
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation
International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362